US equities |
MU $1,088.00 ▲+0.00% NVDA $237.47 ▲+0.00% SNDK $1,692.42 ▲+0.00% INTC $113.12 ▲+0.00% AMD $645.86 ▲+0.00% SPCX $167.60 ▲+0.00% PLTR $194.12 ▲+0.00% META $721.31 ▲+0.00%
FinancialContent

Latest News about Fragile X Syndrome

Recent news which mentions Fragile X Syndrome

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism
Tickers NMLSF
Tags Top Stories Penny Stocks Contracts
From Benzinga
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Tickers KONEF NMLSF
Tags News Cannabis Market News
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Markets Benzinga Fragile X Syndrome
From Benzinga